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Background.Minimallyinvasiveparathyroidectomy (MIP)isincreasinglyreplacing thetraditional bilateral neckexploration in the
treatment of primary hyperparathyroidism (PHP). Intraoperative PTH (IOPTH) measurement has recently been introduced as a
useful adjunct in conﬁrming successful excision of abnormalparathyroid gland. Aims. We evaluate the safety, eﬃcacy, and clinical
usefulness of IOPTH measurement during MIP in a district general hospital. Methods. Retrospective review of eleven consecutive
patients with PHP who underwent MIP with IOPTH, following preoperative assessment with ultrasound and sestamibi scans.
Results. All patients had successful removal of the abnormal parathyroid gland. The concordance rate between ultrasound and
sestamibi scan in localising the parathyroid adenoma was 82%. IOPTH measurement conﬁrmed the removal of adenoma in all
cases and, in one case, led to identiﬁcation of a second adenoma, not localised preoperatively. The median hospital stay was 2
days (range 1–7 days). All patients remained normocalcaemic after a median of 6 months (range 1–10 months). Conclusions.
Minimallyinvasiveparathyroidectomyisafeasible,safe,andeﬀective methodfortreatment ofPHP.TheuseofIOPTHmonitoring
potentiallyoﬀersincreasedsensitivityindetecting multiglandulardisease,canminimisetheneedandriskassociatedwithrecurrent
operations, and may facilitate cost-eﬀective minimally invasive surgery.
1.Introduction
Surgery is currently the only available cure for primary
hyperparathyroidism (PHP) [1]. In selected patients, mini-
mally invasive parathyroidectomy (MIP) oﬀers the beneﬁts
of decreased morbidity and shorter hospital stay; hence, it
is increasingly replacing the traditional bilateral neck explo-
ration (BNE) and four-gland evaluation [2]. This technique
depends on successful preoperative imaging and localiza-
tion of the abnormal gland, using ultrasound (USS) and
Technetium Tc99m sestamibi scanning with single-photon
emission tomography (SPECT) [3]. Using a combination of
these imaging modalities, an adenoma could be localised
with 95% accuracy. However, the two imaging methods are
concordant in only up to 64% of patients with PHP [4], and
their accuracy is decreased in multiglandular disease (MGD)
[5]. Identiﬁcation of a macroscopically abnormal parathy-
roid gland during MIP does not excludeabnormalities of the
rest of the glands such as double adenoma, multiglandular
disease, or malignant tumours, which may be diﬃcult to
distinguish from benign adenomas [6], especially in light
of the above limitations of preoperative imaging. On the
other hand, histopathology of excised abnormal parathyroid
glands is not predictive of the secretory function of the
remaining parathyroid glands left in situ [7]. Intraoperative
parathyroid hormone (IOPTH) measurement has recently
been introduced as a useful adjunct in conﬁrming the
successful excision of a parathyroid adenoma. The method
is based on the short half-life of the intact PTH (4–5
minutes) [8]; successful removal of diseased parathyroid2 International Journal of Endocrinology
tissue is predicted by corresponding decrease of serum PTH
concentrations. We present our initial experience of patients
with PHPtreated surgicallywith minimally invasive parathy-
roidectomy and IOPTH measurement, and we evaluate the
safety, eﬃcacy, and clinical usefulness of the method in a
district general hospital.
2.Subjectsand Methods
The study included eleven consecutive patients (two male
and nine female) who underwent surgery for PHP over 6
months period in a district general hospital serving a popu-
lation of approximately 300,000. The patient characteristics
are presented in Table 1. Ten patients were operated as
elective cases because of severe hypercalcaemia complicated
with decreased bone density. One patient was operated as an
emergency due to extreme hypercalcaemia (adjusted serum
calcium level, 6.49mmol/L) with grossly elevated PTH con-
centration of 1059pg/mL (reference range 15–65pg/mL),
serum phosphate 1.79mmol/L, creatinine 124µmol/L, and
urea 16.0mmol/L [9]. This patient presented acutely with
extreme lethargy, dehydration, and drowsiness. Two weeks
priorto admission, she had sustained right scaphoid fracture
following a fall and was diagnosed with primary hyper-
parathyroidism (PHPT), awaiting elective parathyroidec-
tomy. All eleven patients had ultrasound scan of the neck
preoperatively whereas sestamibi scan was feasible in all
but one patient, who was severely kyphotic. Three patients
underwent planned full neck exploration facilitated by
IOPTH measurements, during the initial period of method
validation. In the remaining 8 patients, MIP surgery was
initiated under general anaesthesia via a 3cm skin crease
incision approximately 1cm above the clavicle and centred
over the anterior border of sternoceidomastoid muscle. All
patients were operated by one surgeon.
Biochemicalproﬁlewasassayed onaCobas6000analyser
(Roche Diagnostics, Mannheim, Germany) using standard
methods. Serum calcium was assayed by a method according
to Schwarzenbach [10] with o-cresolphthalein complexone
and serum albumin was measured by a colourimetric assay
[11]. Intact PTH was assayed by a sandwich electrochemilu-
minescence immunoassay [12]. Intraoperative measurement
of serum PTH was performed at baseline (immediately
after the adenoma was resected, T0) and then at every
5 minutes post excision of the macroscopically abnormal
parathyroid gland for 15 minutes (T5, T10, and T15). A fall
in serum PTH level by at least 50% of the baseline value
within 15 minutes was used to conﬁrm successful removal
of parathyroid adenoma [13].
3.Results
Excision of parathyroid adenoma was followed by the
predicted fall in Intraoperative serum PTH concentration
of >50% in ten patients. In one patient, the PTH levels
increased and remained high for up to 30 minutes post
excision, implying the presence of multiglandular disease;
Table 1: Patient characteristics, preoperative and postoperative
serum calcium, and parathormone levels.
Patient
characteristics
Median Range
Age
Serum vitamin D
(nmol/L)
61 46–67
26 16–35
Gender N %
Male 21 8
Female 98 2
Operation
Elective 10 91
Emergency 19
Patients
Preop
PTH
(pg/mL)
Preop
serum Ca
(mmol/L)
Postop
PTH
(pg/mL)
Postop
serum Ca
(mmol/L)
Pt 1 154 3.13 75 2.63
Pt 2 1059 6.06 28 2.32
Pt 3 1924 3.61 162 2.23
Pt 4 86 2.70 43 2.32
Pt 5 44 3.07 20 2.33
Pt 6 697 3.82 14 2.25
Pt 7 142 2.91 68 2.26
Pt 8 367 4.00 10 2.85
Pt 9 194 2.90 92 2.29
Pt 10 249 3.14 42 2.3
Pt 11 120 2.90 47 2.45
further neck exploration identiﬁed an ipsilateral second ade-
noma, not localised preoperatively by either ultrasound or
sestamibiscan.Removalofthesecondadenomawasfollowed
by the expected fall in serum PTH concentration of >50%
conﬁrming successful surgery (Figure 1). In another patient,
the operation was converted to standard collar incision
because the localised parathyroid adenoma macroscopically
resembled a thyroid nodule; therefore, better access was
deemed necessary; histology conﬁrmed the presence of a
parathyroid adenoma only. In all cases, histology conﬁrmed
the presence of discrete, encapsulated adenomas, containing
sheets and islands of eosenophilic and chief cells, with no
capsular invasion. There was no evidence of hyperplasia
or carcinoma in either of the eleven patients. During the
postoperative period, ten patients had normal PTH and
remained normocalcaemic to a median (range) follow up
of 6 (1–10) months. Recurrent elevation of serum PTH
concentration was noted postoperatively in one patient
despite a fall of >50% of baseline Intraoperatively. The
patient remains normocalcaemic to date. Two patients had
transient clinicalhypocalcaemia (withnadir correctedserum
calcium levels 2.0mmol/L and 2.09mmol/L) and during the
ﬁrst postoperative week requiring calcium and vitamin-D
supplementation orally. No other complication was noted.
The hospital stay of the elective cases was 2 (1–3) days. TheInternational Journal of Endocrinology 3
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Figure 1: Serum PTH concentrations during the Intraoperative
period of minimally invasive parathyroidectomy and at follow up,
expressed as percentage diﬀerence from the baseline value (T0).
T0 represents time of sample taken immediately after resection of
adenoma and then at every 5 minutes up to 15 minutes (T5, T10,
and T15). T0’ represents time of sample taken immediately after
resection of a second adenoma and then every 5 minutes for 15
minutes (T5’, T10’, and T15’). Follow up samples were organised
after a median (range) of 6 (1–10) months.
patient who had parathyroidectomy as an emergency when
admitted with hypercalcaemic crisis stayed in the hospital
for a total of 7 days in order to be monitored for potential
complications of extreme hypercalcaemia.
4.Discussion
Primary hyperparathyroidism is a common condition. The
incidence since the introduction of multichannel analysers
is approximately 1:1000, with the relatively asymptomatic
older female being the typical patient [14]. A prevalence of
up to 2.1% in postmenopausal women has been reported
in population-based health screening [15]. PHP is predom-
inantly a sporadic disorder [16]. However, in the minority
(less than 10%) of aﬀected patients, PHP is associated
with a number of distinct hereditary syndromes including
multiple endocrine neoplasia (MEN) types 1 and 2A (MEN
1, MEN 2A), hyperparathyroidism-jaw tumour (HPT-JT)
syndrome [17], and familial isolated hyperparathyroidism
[18]. PHP is primarily caused by benign single adenoma
in approximately 80% of patients. Multinodular parathyroid
hyperplasia accounts for 15%–20% of cases [19] and only
occasionally PHP is caused by parathyroid carcinoma.
This retrospective study was based on a small prelim-
inary series of patients and is not devoid of the relevant
methodological weaknesses, such as incomplete data (e.g
preoperative levels of 25-OH vitamin D, urine calcium lev-
els),accountedforbylocalpoliciesandtheretrospective data
collection method; these have been addressed in prospective
larger series [20–22]. However, it has demonstrated that
minimally invasive parathyroidectomy is a safe and eﬀective
method of surgical treatment of PHP, constituting a simple
procedurethatcanbecarriedoutinadistrictgeneralhospital
asdaysurgeryorwithovernightstay;mostofourpatientsare
now discharged within 24 hours with calcium and vitamin-
D supplements. Although the role of IOPTH measurement
is debatable, in our study, it incurred substantial clinical
beneﬁt by identifying the correct pathology in one patient
with discordant preoperative imaging and in one patient
with doubleadenoma.Italso facilitatedsuccessfulexcisionof
adenomaswithouttheneedforIntraoperativefrozensection,
which can be disconcordant with the deﬁnitive histology in
up to 10% of cases [23, 24].
SuccessfuloutcomeofMIPnecessitates eﬀectivepreoper-
ative localization of the abnormal parathyroid tissue. Ultra-
sound localizes up to 80% of parathyroid adenomas [25].
Tc99m sestamibi scanning, using either single-photon emis-
sion computed tomography (SPECT) or oblique pinhole
images, is able to localize over 90% of adenomas, including
ectopic glands, but is less accurate in multiglandular disease
[26]. When ultrasound scan (USS) and Technetium Tc99m
sestamibi scanning are concordant their accuracy increases,
but this is feasible in only two thirds of patients with
PHP (best concordance rate 64%) [27]. In our case series,
Intraoperative serum PTH level quantiﬁcation had higher
sensitivity (100%) in detecting the parathyroid pathology
(single or double adenoma) compared to each imaging
technique alone. Concordance between USS, sestamibi scan
and IOPTH was noted in 9 (82%) patients. (Radiologists
were not blinded to USS or sestamibi scan). The false
negative rate for USS alone was 18% (2 in 11 patients) and
forsestamibiscanalone10%(1in10patients).Combination
ofall three methods facilitatedoptimumselection ofpatients
for minimally invasive surgery.
A major beneﬁt yielded by use of IOPTH measurement
in this study was the diagnosis of a double adenoma that
hadnotbeendetectedpreoperatively.Doubleadenomashave
been reported to occur in 2%–15% of patients undergoing
operation for PHP [28]a n dc a nb em i s s e di nu pt o1 5 %
of patients diagnosed with a single adenoma by sestamibi
scan [29, 30]. They have a nonuniform distribution, likely
to involve both sides of the neck and they can easily be
missed when a focused MIP approach is employed. Failure
to recognise the double pathology can lead to unsuccessful
surgical outcome, unnecessary patient distress, and exposure
to the risks of a redo operation and anaesthesia, along with
further potential cost.Failure of serum PTH to appropriately
decrease after excision of a single adenoma should raise
suspicion of additional adenomas and the surgical approach
should be modiﬁed accordingly, if necessary by converting
MIP to a standard full neck exploration.
Although Intraoperative serum PTH level quantiﬁcation
was ﬁrst introduced in 1990, it has yet to be universally
accepted as a routine adjunct in surgery for PHP. Opponents
of the method claim the additional incurring cost of surgery
[31], prolongation of the operating time of MIP and the
reported false negative rate [32]. We did not perform a cost
analysis during this small study, but it is anticipated that the
short median hospital stay of our patients was cost eﬀective;
the additional cost of PTH assays of £32 per patient (4
Intraoperative measurements) has been oﬀset by reducing
the hospital stay (cost of £657 per overnight stay per patient4 International Journal of Endocrinology
[33]) and by eliminating the cost of Intraoperative frozen
section (£150 per patient). The use of IOPTH measurement
in our series added 5–10 minutes extra to the operating time
of minimally invasive procedure. MIP in experienced hands
has beenshown tobeassociated with shorter operatingtimes
[34] comparing to the conventional neck exploration, but
studies providing high levels of evidence are lacking in this
respect.
One patient in our study was found to have elevated
serum PTH during follow up, despite appropriate Intraop-
erative PTH fall after excision of adenoma, but remains nor-
mocalcaemic and asymptomatic; hence, no further imaging
has been deemed clinically necessary. This phenomenon is
not uncommon and its signiﬁcance is uncertain; between
8%–40% of patients with normocalcemia after surgery have
elevated PTH levels at follow up [35, 36]. In a recent study,
Ning et al. [37] demonstrated that 95% of these patients
do not develop recurrent hyperparathyroidism (RHP). Pro-
posed potential risk factors include higher preoperative PTH
concentrations, higher alkaline phosphatase activities, and
older age (associated with impaired renal function, bone
remineralization, and low vitamin D). They supported the
hypothesis that persistently elevated PTH may be, in part,
secondary to “bone hunger” and suggested that RHP in their
series was more likely if postoperative serum calcium was
higher than 9.7mg/dL (2.42 mmol/L). Long follow up with
yearly serum PTH and calcium levels is necessary to detect
potential recurrence at an early stage.
In summary, the results of our small case series suggest
that minimally invasive parathyroidectomy with Intraop-
erative PTH measurement is a feasible, safe, and eﬀective
method for treatment of primary hyperparathyroidism in
the context of a district general hospital. Our ﬁndings are in
accordance with similar studies appealing for its wider use in
the UK [38].
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